The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
Seminar Title
PC1 – Advanced therapy medicial products (ATMPs) – challenging opportunities for hospital pharmacy
Affiliation
Specialist Pharmacy Service, NHS England.
Country
United Kingdom
1. Current Status, Position
Anne Black is a Regional QA Specialist Pharmacist based in the Royal Victoria Infirmary in Newcastle upon Tyne. She is Chair of the Pan UK Pharmacy Working Group for ATMPs and a member of the National Pharmacy Clinical Trials Advisory Group.
2. Education
Anne Black studied Pharmacy in Sunderland University from 1988 – 1991 graduating with a first class honours degree. She undertook further formal studies and obtained the Postgraduate Diploma in Pharmaceutical Technology and Quality Assurance from the University of Leeds. Anne currently teaches sessions on ATMPs now at the University of Manchester and University of Leeds.
3. Research Area
Alongside her interests in clinical trials and safety of injectable medicines, she also developed an interest and expertise in Advanced Therapy Medicinal Products (ATMPs) as she became involved with the quality management of the Newcastle Cellular Therapies Facility. She has since used this expertise to emphasise the important role of Pharmacy to optimise patient safety in the delivery of these innovative medicines. Anne is Chair of the Pan UK Pharmacy Working Group for ATMPs, and a Steering Group Member of the Northern Alliance Advanced Therapy Treatment Centre as well as sitting on NHS Pharmaceutical QA Committee and the National Pharmacy Clinical Trials Advisory Group
4. Conflict of interest
Has served on an advisory board which are funded by industry in the last 24 months